These people must not have read your "report" when they paid $5.mil for this product.
(BSNS WIRE) CTI Announces First Sale of its New Breast Cancer Imaging Syste
CTI Announces First Sale of its New Breast Cancer Imaging System; Unique
Non-Invasive Advancement Aids Physicians in Diagnosis of Breast Cancer
Business Editors
LAYTON, Utah--(BUSINESS WIRE)--June 19, 2000--Computerized Thermal
Imaging, Inc. (CTI) (OTC symbol: COII) announced today the sale of 10
CTI breast cancer imaging systems to a Latin American consortium based
in Mexico City for $5 million.
This consortium, Computerized Thermal Imaging International, and
CTI had previously announced an agreement to deploy 100 CTI breast
cancer imaging units in Latin America. This initial purchase order was
accompanied by a down payment of $1.75 million, with the balance due
upon delivery of the systems.
"This is a very significant event in our corporate history,"
stated David Packer, President and COO. "It represents the first sale
of our revolutionary breast cancer imaging system and our first
significant revenues. This achievement is the result of our unwavering
commitment to bring this product to market successfully. Our recent
acquisition of Bales Scientific will greatly enhance both production
and support. We will now begin production as well as total
implementation of the domestic and international product support
infrastructure."
CTI is seeking FDA approval for use of its Computerized Thermal
Imaging System in the United States as an adjunctive diagnostic test
to mammography and clinical examination for the detection of breast
cancer. The test is simple, painless, and involves no radiation,
breast compression, electrodes, electrical current, or skin contact.
CTI also recently announced evaluation of their technology for new
occupational medicine applications.
Computerized Thermal Imaging, Inc. is in business to improve the
quality of life through superior diagnostics. Information about CTI
can be found on the Internet at www.cti-net.com or by calling CTI
Public Affairs at (801) 926-1113.
Except for historical information contained herein, the matters
discussed in this news release are forward-looking statements that
involve risks and uncertainties. The forward-looking statements are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. In addition to the factors set forth
above, other important factors that could cause actual results to
differ materially include, but are not limited to technical risks
associated with new technology development, government regulatory
approvals or continued working capital. Additional information
concerning factors that could cause actual results to differ
materially from those in the forward-looking statements is contained
from time to time in the Company's SEC filings. Copies of these
filings may be obtained by contacting the Company or the SEC.
--30--ts/sd*
CONTACT: Computerized Thermal Imaging, Inc.
Dee Rose, 801/926-1113
KEYWORD: UTAH INTERNATIONAL LATIN AMERICA
INDUSTRY KEYWORD: PHARMACEUTICAL BIOTECHNOLOGY MEDICAL
COMPUTERS/ELECTRONICS
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com |
